FDA Warns Against Use of Terbutaline to Treat Pre-Term Labor


FDA's warning on terbutaline: "The U.S. Food and Drug Administration (FDA) is warning the public that injectable terbutaline should not be used in pregnant women for prevention or prolonged treatment (beyond 48-72 hours) of preterm labor in either the hospital or outpatient setting because of the potential for serious maternal heart problems and death."




Tags: fda, labor, preterm, terbutaline, warning

Views: 1

Reply to This


Follow My Best Birth on Twitter or join us on Facebook.


© 2015   Created by MyBestBirth Admin.   Powered by

Badges  |  Report an Issue  |  Terms of Service